| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Haymaker Acquisition Corp. II (HYACU) (u) | Cantor | 30.00 | $10.00 | $10.00 | $300.00 | n.a. |
| Fellazo (FLLCU) (u) | Maxim Group | 5.00 | $10.00 | $10.00 | $50.00 | n.a. |
| Biophytis SA (BPTS) | H.C. Wainwright & Co. | $15.00 | n.a. | |||
| Meten International Education Group (MEDU) | Citigroup/ CICC/ Macquarie Capital | $100.00 | n.a. | |||
| Priam Properties (PRIM) | BofA Merrill Lynch/ Baird/ RBC Capital Markets/ Stifel | $100.00 | n.a. | |||
| Endeavor Group Holdings (EDR) | Goldman Sachs/ KKR/ J.P. Morgan/ Morgan Stanley/ Deutsche Bank Securities | $100.00 | n.a. | |||
| Stoke Therapeutics (STOK) | J.P. Morgan/ Cowen/ Credit Suisse | $86.25 | n.a. | |||
| Personalis (PSNL) | Morgan Stanley/ BofA Merrill Lynch/ Cowen and Company | $115.00 | n.a. | |||
| Akero Therapeutics (AKRO) | J.P. Morgan/ Jefferies/ Evercore ISI | $86.25 | n.a. | |||
| Prevail Therapeutics (PRVL) | Morgan Stanley/ BofA Merrill Lynch/ Cowen and Company | $100.00 | n.a. | |||
| Dermavant Sciences (DRMT) | Jefferies/ SVB Leerink/ Guggenheim Securities | $100.00 | n.a. | |||
| BridgeBio Pharma (BBIO) | J.P. Morgan/ Goldman Sachs/ Jefferies/ SVB Leerink/ KKR/ Piper Jaffray/ Mizuho Securities/ BMO Capital Markets/ Raymond James | $225.00 | n.a. | |||
| Atreca (BCEL) | Cowen/ Evercore ISI/ Stifel | $100.00 | n.a. | |||
| To Prosperity Technology (BCHT) | TBA | $8.00 | n.a. | |||
| n.a. (not available) | ||||||
| TBA (to be announced) | ||||||
| u = unit offering | ||||||
| Postponed | ||||||
| Peloton Therapeutics (PLTX) | J.P. Morgan/ Citigroup/ Jefferies | 9.38 | $15.00 | $17.00 | $150.00 | n.a. |
| Withdrawn | ||||||
| Cibus Global (CBUS) | Morgan Stanley/ BofA Merrill Lynch/ Piper Jaffray | 6.67 | $14.00 | $16.00 | $100.00 | n.a. |
| New Terms | ||||||
| Mohawk Group Holdings (MWK) | Roth Capital Partners/ A.G.P. | 3.33 | $14.00 | $16.00 | $50.00 | S/O. |
| GSX Techedu (GSX) | Credit Suisse/ Deutsche Bank Securities | 19.80 | $9.50 | $11.50 | $207.90 | S/O. |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 20, 2019 | Manager(s) | Offered | Raised | Price | 5/24/19 | Change |
| IDEAYA Biosciences (IDYA) | J.P. Morgan/ Citigroup/ Jefferies | 5.00 | $50.00 | $10.00 | $11.25 | 12.50% |
| Rattler Midstream (RTLR) | Credit Suisse/ BofA Merrill Lynch/ J.P. Morgan | 38.00 | $665.00 | $17.50 | $18.90 | 8.00% |
| GX Acquisition (GXGXU) (u) | Cantor | 25.00 | $250.00 | $10.00 | $10.06 | 0.55% |
| Bicycle Therapeutics Limited (BCYC) | Goldman Sachs/ Jefferies/ Piper Jaffray | 4.33 | $60.67 | $14.00 | $13.05 | -6.79% |
| u = unit offering | ||||||
